Acepodia, Inc. (TPEX:6976)
14.90
-0.35 (-2.30%)
At close: Dec 5, 2025
Acepodia Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 0.3 | 0.43 | 16.59 | - | - | - |
| Revenue Growth (YoY) | -98.22% | -97.43% | - | - | - | - |
| Cost of Revenue | 0.12 | 0.15 | - | - | - | - |
| Gross Profit | 0.18 | 0.28 | 16.59 | - | - | - |
| Selling, General & Admin | 155.49 | 145.52 | 141.63 | 175.97 | 173.84 | 34.12 |
| Research & Development | 731.43 | 612.66 | 310.94 | 341.59 | 303.45 | 115.53 |
| Operating Expenses | 886.92 | 758.18 | 452.57 | 517.56 | 477.29 | 149.64 |
| Operating Income | -886.74 | -757.9 | -435.97 | -517.56 | -477.29 | -149.64 |
| Interest Expense | -6.57 | -6.49 | -4.84 | -1.51 | -0.8 | -0.06 |
| Interest & Investment Income | 252.69 | 275.26 | 132.24 | 25.55 | 0.42 | 0.28 |
| Currency Exchange Gain (Loss) | -8.99 | 16.32 | -25.4 | 4.37 | -1.49 | -2.57 |
| Other Non Operating Income (Expenses) | 7.04 | -0.09 | -481.23 | -925.24 | -399.36 | -302.97 |
| EBT Excluding Unusual Items | -642.57 | -472.91 | -815.21 | -1,414 | -878.51 | -454.96 |
| Gain (Loss) on Sale of Assets | 0.03 | -0.09 | -1.51 | - | - | - |
| Other Unusual Items | - | 0 | 0.17 | 0.01 | - | - |
| Pretax Income | -642.55 | -472.99 | -816.54 | -1,414 | -878.51 | -454.96 |
| Income Tax Expense | 13.01 | 23.76 | 0.78 | - | - | - |
| Net Income | -655.56 | -496.75 | -817.32 | -1,414 | -878.51 | -454.96 |
| Net Income to Common | -655.56 | -496.75 | -817.32 | -1,414 | -878.51 | -454.96 |
| Shares Outstanding (Basic) | 575 | 570 | 567 | 46 | 45 | 45 |
| Shares Outstanding (Diluted) | 575 | 570 | 567 | 46 | 45 | 45 |
| Shares Change (YoY) | -18.22% | 0.58% | 1134.31% | 1.56% | 0.07% | - |
| EPS (Basic) | -1.14 | -0.87 | -1.44 | -30.79 | -19.42 | -10.07 |
| EPS (Diluted) | -1.14 | -0.87 | -1.44 | -30.79 | -19.42 | -10.07 |
| Free Cash Flow | -652.93 | -493.91 | -462.09 | -380.49 | -386.59 | -107.02 |
| Free Cash Flow Per Share | -1.14 | -0.87 | -0.81 | -8.28 | -8.55 | -2.37 |
| Gross Margin | 61.13% | 65.11% | 100.00% | - | - | - |
| Operating Margin | -294596.68% | -177493.91% | -2627.46% | - | - | - |
| Profit Margin | -217792.36% | -116334.43% | -4925.69% | - | - | - |
| Free Cash Flow Margin | -216921.26% | -115669.55% | -2784.83% | - | - | - |
| EBITDA | -830.3 | -723.24 | -423.71 | -506.97 | -471.47 | -146.75 |
| D&A For EBITDA | 56.44 | 34.66 | 12.27 | 10.59 | 5.82 | 2.89 |
| EBIT | -886.74 | -757.9 | -435.97 | -517.56 | -477.29 | -149.64 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.